美股異動丨匯豐控股(HSBC.US)盤前跌4.6% 第三季列賬基準除税前利潤跌42%
格隆匯10月25日丨匯豐控股(HSBC.US)盤前跌4.6%,報25.7美元。匯豐控股今日午間公佈,2022年第三季度,列賬基準除税後利潤減少17億美元,降至26億美元,減幅為40%;列賬基準除税前利潤減少23億美元,降至31億美元,減幅為42%。列賬基準收入減少3%,降至116億美元。如市場預期,匯豐於第三季度不派息。三季度錄得10.75億美元預期信貸損失(ECL),環比擴大1.4倍,而去年同期為淨回撥6.59億美元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.